Basic and Translational Science in Heart Failure

心力衰竭的基础和转化科学

基本信息

  • 批准号:
    9924622
  • 负责人:
  • 金额:
    $ 33.74万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-04-01 至 2022-03-31
  • 项目状态:
    已结题

项目摘要

ABSTRACT While cardiovascular disease (CVD) remains the leading cause of morbidity and mortality in the US, the mortality burden of specific diseases has changed over the last few decades. Despite a decline in death rates for coronary artery disease since 1970, heart failure (HF) prevalence and mortality have increased. The expanded clinical burden, prognostic import, and health needs related to HF highlight the importance of complementary training of teams of basic, clinical, and population scientists. Hence, we propose the Basic and Translational Science in Heart Failure (BTSHF) Training Program, designed to specifically mentor clinical and research post-doctoral trainees in broad aspects of HF pathophysiology (disease mechanisms), diagnostics (biomarkers and imaging), therapeutics (pharmacological, biological, devices), epidemiology (population science, personalized medicine, and clinical outcomes), as well as relevant methodologies (disease models, stem cells, ‘omics’ approaches, and biostatistics). At the heart of the training program reside three thematic cores - Cellular and Molecular Mechanisms; New Diagnostics and Therapeutics; and Clinical Epidemiology and Outcomes. In close collaboration with the University of Alabama at Birmingham (UAB) Office of Postdoctoral Education and Center for Clinical and Translational Science, the 2 to 3 year BTSHF training program has been specifically tailored to foster the development of future translational researchers with scientific interests in HF. This includes establishment of a new interdisciplinary didactic course that exposes trainees to cutting edge scientific techniques (e.g., non-invasive imaging, translational study design, large data set analysis) and concepts (e.g., cardiometabolics, epigenetics, inflammation, tissue regeneration). The program also takes advantage of multiple seminar series and symposia organized by various UAB Departments and Centers, including the Comprehensive Cardiovascular Center. A diverse group of primary faculty from multiple Departments/Schools have been assembled, who possess established track records in HF related research and/or mentorship, as well as several secondary and junior faculty, whose collective expertise span the three scientific cores. Highly meritorious MD and PhD fellows will be recruited and matched with a mentoring team consisting of four complementary faculty mentors from the distinct scientific cores, including one junior faculty. Trainee progress and mentorship effectiveness will be evaluated at regular intervals, and facilitated throughout the training period by established mechanisms, including mentoring roundtables. The proposed program is enriched further by the highly collaborative and interdisciplinary environment afforded by our institution, which has a longstanding track record in both cardiovascular and translational research, as well as in mentorship of future independent researchers and scientific leaders. Establishment of the BTSHF program will ensure adequate training of future translational researchers armed with the appropriate skills to tackle the growing HF epidemic.
摘要 虽然心血管疾病(CVD)仍然是美国发病率和死亡率的主要原因, 过去几十年来,特定疾病的死亡率负担发生了变化。尽管死亡率有所下降 自1970年以来,冠状动脉疾病的心力衰竭(HF)患病率和死亡率增加。的 扩大的临床负担、预后意义和与HF相关的健康需求强调了以下方面的重要性: 对基础、临床和人口科学家团队进行补充培训。因此,我们建议基本 和心力衰竭转化科学(BTSHF)培训计划,旨在专门指导 HF病理生理学(疾病机制)广泛方面的临床和研究博士后学员, 诊断学(生物标志物和成像)、治疗学(药理学、生物学、器械)、流行病学 (人口科学,个性化医疗和临床结果),以及相关的方法 (疾病模型、干细胞、“组学”方法和生物统计学)。培训计划的核心是 三个主题核心-细胞和分子机制;新的诊断和治疗;和临床 流行病学和结果。与亚拉巴马大学伯明翰分校(UAB)办公室密切合作 博士后教育和临床与转化科学中心,2至3年BTSHF培训 该计划专门为促进未来翻译研究人员的发展而量身定制 对HF有科学兴趣这包括建立一个新的跨学科教学课程, 让受训者接触尖端的科学技术(例如,非侵入性成像,转化研究设计, 大数据集分析)和概念(例如,心脏代谢、表观遗传学、炎症、组织再生)。 该计划还利用多个研讨会系列和研讨会组织的各种UAB的优势 部门和中心,包括综合心血管中心。一个多样化的小学生群体 来自多个部门/学校的教师已经聚集,谁拥有既定的跟踪记录, HF相关的研究和/或指导,以及几个中学和初中教师,其集体 专业知识跨越三大科学核心。将招募非常优秀的MD和PhD研究员, 与由四名来自不同学院的互补教师导师组成的指导团队相匹配 科学核心,包括一个初级教师。将评估学员的进度和指导效果 在整个培训期间,由现有机制提供便利, 指导圆桌会议。拟议的方案进一步丰富了高度协作和 我们的机构提供的跨学科环境,在这两个方面都有长期的记录 心血管和转化研究,以及未来独立研究人员的导师, 科学领袖BTSHF计划的建立将确保未来的充分培训 翻译研究人员配备了适当的技能,以应对日益增长的HF流行病。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sumanth D Prabhu其他文献

Sumanth D Prabhu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sumanth D Prabhu', 18)}}的其他基金

Cardiac Macrophages as Disease Drivers in Chronic Ischemic Heart Failure
心脏巨噬细胞作为慢性缺血性心力衰竭的疾病驱动因素
  • 批准号:
    10228245
  • 财政年份:
    2021
  • 资助金额:
    $ 33.74万
  • 项目类别:
Cardiac Macrophages as Disease Drivers in Chronic Ischemic Heart Failure
心脏巨噬细胞作为慢性缺血性心力衰竭的疾病驱动因素
  • 批准号:
    10592811
  • 财政年份:
    2021
  • 资助金额:
    $ 33.74万
  • 项目类别:
Cardiac Macrophages as Disease Drivers in Chronic Ischemic Heart Failure
心脏巨噬细胞作为慢性缺血性心力衰竭的疾病驱动因素
  • 批准号:
    10613345
  • 财政年份:
    2021
  • 资助金额:
    $ 33.74万
  • 项目类别:
Macrophage Circadian Clock Disruption and Inflammation in Heart Failure
心力衰竭中的巨噬细胞生物钟破坏和炎症
  • 批准号:
    9901568
  • 财政年份:
    2019
  • 资助金额:
    $ 33.74万
  • 项目类别:
Macrophage Circadian Clock Disruption and Inflammation in Heart Failure
心力衰竭中的巨噬细胞生物钟破坏和炎症
  • 批准号:
    10597351
  • 财政年份:
    2019
  • 资助金额:
    $ 33.74万
  • 项目类别:
Macrophage Circadian Clock Disruption and Inflammation in Heart Failure
心力衰竭中的巨噬细胞生物钟破坏和炎症
  • 批准号:
    9764124
  • 财政年份:
    2019
  • 资助金额:
    $ 33.74万
  • 项目类别:
6th Annual Comprehensive Cardiovascular Center (CCVC) Symposium: Focus on Cardiovascular Electrophysiology
第六届综合心血管中心(CCVC)年度研讨会:聚焦心血管电生理学
  • 批准号:
    9397864
  • 财政年份:
    2017
  • 资助金额:
    $ 33.74万
  • 项目类别:
Role of Regulatory T-Lymphocytes in Chronic Heart Failure
调节性 T 淋巴细胞在慢性心力衰竭中的作用
  • 批准号:
    9111666
  • 财政年份:
    2015
  • 资助金额:
    $ 33.74万
  • 项目类别:
Splenic Marginal Zone Macrophages in Chronic Ischemic Heart Failure
慢性缺血性心力衰竭中的脾边缘区巨噬细胞
  • 批准号:
    9211359
  • 财政年份:
    2015
  • 资助金额:
    $ 33.74万
  • 项目类别:
Role of Regulatory T-Lymphocytes in Chronic Heart Failure
调节性 T 淋巴细胞在慢性心力衰竭中的作用
  • 批准号:
    8922490
  • 财政年份:
    2015
  • 资助金额:
    $ 33.74万
  • 项目类别:

相似海外基金

Alterations in macrophage metabolism in heart failure with preserved ejection
射血保留性心力衰竭患者巨噬细胞代谢的改变
  • 批准号:
    502586
  • 财政年份:
    2024
  • 资助金额:
    $ 33.74万
  • 项目类别:
SBIR Phase II: In-vivo validation of a volume-manufacturable and factory-calibrated wearable NT-proBNP monitoring system for heart failure treatment
SBIR II 期:用于心力衰竭治疗的可批量生产和工厂校准的可穿戴 NT-proBNP 监测系统的体内验证
  • 批准号:
    2335105
  • 财政年份:
    2024
  • 资助金额:
    $ 33.74万
  • 项目类别:
    Cooperative Agreement
RAPHAEL - Integrating a Palliative Care Approach for Patients with Heart Failure
RAPHAEL - 为心力衰竭患者整合姑息治疗方法
  • 批准号:
    10112701
  • 财政年份:
    2024
  • 资助金额:
    $ 33.74万
  • 项目类别:
    EU-Funded
Exploratory research to elucidate the molecular mechanisms by which depression makes heart failure more severe and to reconstruct heart failure treatment strategies.
探索性研究旨在阐明抑郁症使心力衰竭更加严重的分子机制,并重建心力衰竭治疗策略。
  • 批准号:
    23K07507
  • 财政年份:
    2023
  • 资助金额:
    $ 33.74万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Aging of cardiac fibroblasts and heart failure: novel heart failure treatment through regeneration and transplantation of cardiac fibroblasts
心脏成纤维细胞的衰老和心力衰竭:通过心脏成纤维细胞的再生和移植治疗心力衰竭
  • 批准号:
    23K07526
  • 财政年份:
    2023
  • 资助金额:
    $ 33.74万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidating the Intricate Interplay between Mitochondria, Innate Immunity, and Viral Pathogenesis in Heart Failure
阐明心力衰竭中线粒体、先天免疫和病毒发病机制之间复杂的相互作用
  • 批准号:
    491149
  • 财政年份:
    2023
  • 资助金额:
    $ 33.74万
  • 项目类别:
    Fellowship Programs
Comparison of Machine Learning and Conventional Statistical Modeling for Predicting Readmission Following Acute Heart Failure Hospitalization
机器学习与传统统计模型预测急性心力衰竭住院后再入院的比较
  • 批准号:
    495410
  • 财政年份:
    2023
  • 资助金额:
    $ 33.74万
  • 项目类别:
Elucidation of the precise mechanism of heart failure prevention by beta-catenin inhibition enabling the future development of a novel class of medicine
阐明β-连环蛋白抑制预防心力衰竭的精确机制,有助于未来开发一类新型药物
  • 批准号:
    23K15167
  • 财政年份:
    2023
  • 资助金额:
    $ 33.74万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Novel ventricular arrhythmias mechanism in ischemic heart failure focusing on neuropeptide Y
以神经肽Y为重点的缺血性心力衰竭室性心律失常新机制
  • 批准号:
    23K15119
  • 财政年份:
    2023
  • 资助金额:
    $ 33.74万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of novel pathophysiology and development of treatment for heart failure using human iPS cell-derived 3D heart tissue
利用人 iPS 细胞衍生的 3D 心脏组织阐明新的病理生理学并开发心力衰竭治疗方法
  • 批准号:
    23K15140
  • 财政年份:
    2023
  • 资助金额:
    $ 33.74万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了